Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes Therapy"
DOI: 10.1007/s13300-020-00903-0
Abstract: Liraglutide is a glucagon-like peptide-1 analogue used to treat type 2 diabetes mellitus (T2DM). To date, limited long-term data (> 2 years) exist comparing real-world diabetes-related effectiveness and costs for liraglutide versus insulin treatment. This retrospective… read more here.
Keywords: related effectiveness; liraglutide insulin; year; type diabetes ... See more keywords
Combination use of liraglutide and insulin to Japanese patients with multiple insulin injection: efficacy and cost
Sign Up to like & getrecommendations! Published in 2019 at "Diabetology International"
DOI: 10.1007/s13340-019-00404-x
Abstract: Objectives The introduction of liraglutide in the treatment of patients with type 2 diabetes already taking insulin is still subject to discussion in terms of timing and benefits. Gradually intensive insulin therapy is hastily prescribed.… read more here.
Keywords: insulin; multiple insulin; liraglutide insulin; mmol mol ... See more keywords
Fixed-ratio combination therapy with GLP-1 receptor agonist liraglutide and insulin degludec in people with type 2 diabetes
Sign Up to like & getrecommendations! Published in 2017 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2017.1313109
Abstract: ABSTRACT Introduction: A fixed combination of basal insulin degludec and glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide (IDegLira; 50 units degludec/1.8 mg liraglutide) has been developed as a once daily injection for the treatment of type… read more here.
Keywords: insulin; combination; liraglutide insulin; type diabetes ... See more keywords